对老年重创患者创伤引起的凝血病风险因素的分析
Yangbo Kang1,2,3, Qi Yang1,2,3, Hongbo Ding1,2,3
1Department of Emergency Medicine, the Second Affiliated Hospital Zhejiang University School of Medicine / Institute of Emergency Medicine of Zhejiang University, Hangzhou 310009, China.
World journal of emergency medicine
|November 27, 2024
概括
老年患者的创伤诱导凝血病 (TIC) 与较高的损伤严重程度得分和冲击指数有关. 酸化症,低血症和低纤维素生成症是重大创伤后发展TIC的关键危险因素.
科学领域:
- 创伤和紧急医疗医学
- 血液学和凝血障碍 血液学和凝血障碍
- 老年人重症监护中心的重症监护服务.
背景情况:
- 创伤引起的凝血病 (TIC) 在严重受伤的老年患者中显著增加死亡率和发病率.
- 在这个人口群体中,有助于ICT的风险因素仍然不完全理解.
- 这项研究调查了老年人中重大创伤病例中TIC的特定风险因素.
研究的目的:
- 确定和分析与老年患者创伤诱导凝血病 (TIC) 相关的独立风险因素.
- 在这个脆弱的患者群体中开发ICT的预测模型.
- 通过了解老年创伤患者凝血病的预测因素来改善临床结果.
主要方法:
- 对2015年1月至2020年9月期间入院的老年创伤患者进行了一项回顾性研究.
- 人口统计数据,损伤特征,治疗干预措施和临床结果从电子病历中提取.
- 使用多变量逻辑回归和ROC曲线分析来识别独立的风险因素并评估模型性能.
主要成果:
- 在371名老年创伤患者中,34.8%被诊断为TIC.
- 较高的伤害严重性得分 (ISS) 和冲击指数 (SI) 与TIC有显著的关联.
- 在TIC组中观察到较低的血清,纤维素水平和基过量 (BE).
- 确定的独立风险因素包括ISS>16,SI>1,低BE,低血和低纤维素生成血.
- 预测模型表现出强的性能,AUC为0.887.
结论:
- 升高的ISS (>16) 和SI (>1) 是老年创伤患者TIC风险的重要指标.
- 代谢障碍,如酸症 (低BE),低血症和低纤维素生成血症是TIC的关键独立风险因素.
- 这些发现可以帮助在老年创伤患者中早期识别和管理TIC.
相关概念视频
Coagulation
4.8K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
4.8K
Extrinsic and Intrinsic Pathways of Hemostasis
5.6K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.6K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
623
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
623
Disorders of Hemostasis
710
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
710
Introduction to Hemostasis
5.7K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
5.7K


